Global Biosimilars Market Size is Projected to Gain USD 103.94 Billion, at a CAGR of 25.6% by 2022 to 2028 | Vantage Market Research
September 21, 2022 07:28 ET
|
Vantage Market Research
WASHINGTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Biosimilars Market finds that the increasing chronic diseases and rising cost effectiveness of...
Biosimilars Market worth $44.7 billion by 2026 - Exclusive Report by MarketsandMarkets™
July 26, 2022 10:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, July 26, 2022 (GLOBE NEWSWIRE) -- Biosimilars Market size is projected to reach USD 44.7 billion by 2026 from USD 15.6 billion in 2021, at a CAGR of 23.5% during the forecast period of 2021...
With 21.5% CAGR, Global Biosimilars Market Size Worth USD 87.12 Billion in 2030, Growth Plus Reports
July 05, 2022 08:06 ET
|
Growth Plus Reports
Pune, July 05, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market is expected to clock US$ ~87.12 billion by 2030 due to a robust pipeline for biosimilars and increasing demand for biosimilars....
Global Biosimilars Market is estimated close to $18 billion (2020), growing at a Double-Digit Rate
March 07, 2022 08:45 ET
|
Medi-Tech Insights
BRUSSELS, Belgium, March 07, 2022 (GLOBE NEWSWIRE) -- Summary: Medi-Tech Insights: The biosimilars market growth is driven by growing number of biosimilar approvals and rising number of...
Biosimilars Market to Reach USD 103.94 Billion by 2028 - Low Priced Biosimilars to Boost the Market Demand – Vantage Market Research
February 14, 2022 03:39 ET
|
Vantage Market Research
WASHINGTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market size is expected to reach USD 103.94 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 25.6% during the...
Biosimilars Market Size to Surpass US$ 66.2 Billion by 2030
November 18, 2021 11:00 ET
|
Precedence Research
Ottawa, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The global biosimilars market size was reached at US$ 13.2 billion in 2020. The rising prevalence of diseases and the effective treatment of these chronic...
U.S. Biosimilars Market to Expand at 54.7% CAGR; Increasing Demand from the Unmet Populace to Create Growth Opportunities, says Fortune Business Insights
August 16, 2019 09:00 ET
|
Fortune Business Insights
Pune, Aug. 16, 2019 (GLOBE NEWSWIRE) -- The U.S. Biosimilars Market will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by...
Biosimilars Market Size to Reach $26.7 Billion by 2024: P&S Intelligence
April 15, 2019 02:00 ET
|
Prescient & Strategic Intelligence
NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Intelligence, biosimilars market is expected to generate $26.7 billion revenue by 2024,...
Biosimilars Market Size Is Projected To Reach $41.7 Billion, Demand In Various End-use Industries Till 2024: Grand View Research, Inc.
July 19, 2016 05:00 ET
|
Grand View Research
San Francisco, July 19, 2016 (GLOBE NEWSWIRE) -- The biosimilars market is expected to reach USD 41.7 billion by 2024, according to a new report by Grand View Research, Inc. The global...